BPC-157 is a synthetic 15-amino-acid peptide investigated in experimental research. This overview summarizes cited studies and their limitations; it does not provide instructions for human use.

Proper storage preserves peptide quality.

• Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; minimize moisture exposure.

• Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); prepare aliquots if needed and avoid freeze–thaw.

• Allow vials to reach room temperature before opening to reduce condensation uptake.

BPC-157 is a synthetic peptide corresponding to a partial sequence of human gastric juice protein[2]. Preclinical studies suggest it modulates nitric oxide pathways and growth-factor expression to promote angiogenesis and collagen deposition in damaged tissues[1][3]. Experiments using rat tendon explants and cultured tendon fibroblasts reported increased tissue outgrowth and cell migration[6]. These laboratory observations do not demonstrate treatment efficacy in people. A Phase I oral safety trial has been completed[9], and a small human case series reported improvements following intra-articular administration[5]; however, large-scale controlled human efficacy data are not yet available.

Observations from preclinical and early clinical literature.

• Supports tissue repair in gut, tendon, muscle, and skin injury models (animal data)[1][3].

• Rat-derived tendon-cell experiments reported improved cell survival during oxidative stress[6]. This is laboratory evidence.

• Phase I safety studies report good tolerability with no serious adverse events at tested doses[9].

• Occasional mild injection-site reactions (redness, itch) may occur with subcutaneous administration.

• Reference [4] reviews experimental research; it does not establish long-term safety or clinical effectiveness in humans.